Seeking Alpha

TIMCO » Comments » CSKI

  • China Biotech in Review: Entering a New Phase? [View article]
    Your update on CSKI should be updated with this as well:

    Asensio.com

    June 02, 2009

    The China Sky Routine: Another Press Release, Another Unimportant Drug.

    Today China Sky One Medical, Inc. (NASDAQ: CSKI) issued a press release stating that the company had received production approval for yet another drug, diclofenac sodium eye drops. The press release states that the eye drops product is expected to contribute $0.5 million to revenues in its first year of sales.

    Diclofenac is a standard anti-inflammatory drug used for a wide range of purposes. In some countries, diclofenac is approved for over-the-counter use, and for eye drops. Diclofenac eye drops are used to treat non-bacterial inflammation of the anterior part of the eyes, especially with postoperative treatment following cataract surgery, as an alternative to steroids.

    The only interesting issue here is why China Sky chooses to issue a press release for a product that is not proprietary, that has limited uses, and that will, according to the company, produce sales comprising 0.4% of the $128 million in revenues included in the company’s 2009 guidance. China Sky did not disclose if they would earn a profit on the sales. And of course, the release sheds no new light on China Sky’s unexplained low inventory and high margins.
    Jun 07 17:03 pm |Rating: 0 -2 |Link to Comment
  • China Sky One Climbs on Strong 2008 Report [View article]
    Dr. Balaban:

    With all due respect, please visit the truth at
    asensio.com




    On Apr 17 05:07 AM balabanovj wrote:

    > This by far the best managed Chinese pharma. In addition to expanding
    > their OTC offerings, they are also now getting into prescription
    > drugs, injectables and are setting up to offer biologicals as well(antibodies
    > and stem cell products). They will also be receiving CE certification,
    > which will allow them to export to the EU. This is the only Chinese
    > pharma I can think of that stands any chance of becoming a Chinese
    > J&J. If they keep on their current course, 20 years from now,
    > that's exactly what they will be!
    >
    > James B. Balaban, M.D.
    Apr 20 16:28 pm |Rating: 0 -1 |Link to Comment
More on CSKI by TIMCO
Comments by Ticker
TIMCO's
Comments Stats
7 comments
Rating: -2 (3 - 5 )